Tong Yigang

Date:2024-10-09


Name: Tong Yigang

Title: Professor

Landline: 010-64451781

Mailbox: tongyigang@mail.buct.edu.cn

Office address: Room 305, Science and Technology Building


Education background:

1984.9-1988.6, Fudan University, Department of Genetics, Bachelor

1988.9-1991.6, Academy of Military Medical Sciences, Master

1997.9-2000.6, Academy of Military Medical Sciences, Ph.D.

2003.4-2005.4, UBC, Canada, Postdoc (Won the Micheal Smith Award)


Work experience :

1991.7-1997.8   General Hospital of Beijing Military Region

2005.5-2018.5  Beijing Institute of Microbiology and Epidemiology

2018.6-Now    College of Life Science and Technology, Beijing University of Chemical Technology, Dean


Academic title: Professor


The main research areas:

Virology, antivirals, vaccines, bacteriophage, bioinformatics


Academic achievements:

Dr. Yigang Tong has published more than 350 papers in international journals such as Nature, Cell, PNAS, Lancet, etc. His major research interests are emerging infectious diseases, antiviral therapeutics, mRNA vaccine, and bacteriophage. He had served as Chief scientist of China's medical team to fight Ebola outbreak in Africa, as well as group leader of the Chinese Animal and Environment Team of the WHO-China Joint Mission on SARS-CoV-2 origin investigation. His research on the evolution of Ebola virus was rated as one of the top ten scientific advances in China in 2015. He and colleagues developed a bioinformatics method for identifying the termini of phage genomes using the raw sequencing data, and also established a bioinformatic method for detecting functional prophages in the bacterial genome. He is a member of the International Committee for Classification of Viruses (ICTV) in the Bacterial Viruses Subcommittee. 


Representative works:

1.   1. Tong YG*, Shi WF, Liu D, Qian J, Liang L, Bo XC, Liu J, Ren HG, Fan H, Ni M, Sun Y, Jin Y, Teng Y, Li Z, Kargbo D, Dafae F, Kanu A, Chen CC, Lan ZH, Jiang H, Luo Y, Lu HJ, Zhang XG, Yang F, Hu Y, Cao YX, Deng YQ, Su HX, Sun Y, Liu WS, Wang Z, Wang CY, Bu ZY, Guo ZD, Zhang LB, Nie WM, Bai CQ, Sun CH, An XP, Xu PS, Zhang XL, Huang Y, Mi ZQ, Yu D, Yao HW, Feng Y, Xia ZP, Zheng XX, Yang ST, Lu B , Jiang JF, Kargbo B, He FC, Gao GF, Cao WC. Genetic diversity and evolutionary dynamics of Ebola virus in Sierra Leone. Nature 2015:524:93-6. (First author)

2.   2.   Peng Zhou*, Hang Fan*, Tian Lan*, Weifeng Shi*, Wei Zhang, Yan Zhu, Ya-Wei Zhang, Qing-Mei Xie, Shailendra Mani, Xiao-Shuang Zheng, Xing-Lou Yang, Bei Li, Jin- Man Li, Hua Guo, Guang-Qian Pei, Xiao-Ping An, Jun-Wei Chen, Ling Zhou, Kai-Jie Mai, Zi-Xian Wu, Danelle Anderson, Li-Biao Zhang, Shi-Yue Li, Zhi-Qiang Mi, Tong-Tong He, Yun Luo, Xiang-Ling Liu, Jing Chen, Yong Huang, Qiang Sun, Xiang-Li-Lan Zhang, Yan-Shan Chen, Yuan Sun, Juan Li, Feng Cong, Pei-Ju Guo, Ren Huang, Di Li, Yuan-Yuan Wang, Shao-Zhen Xing, Peter Daszak#, Lin-Fa Wang#, Zhengli Shi#, Yigang Tong#, Jing-Yun Ma#. Fatal Swine Disease Outbreak Caused by a Novel HKU2- related Coronavirus of Bat Origin. Nature 2018;556:255-258. (Co-corresponding author)

3.    3Tommy Tsan-Yuk Lam, Na Jia, Ya-Wei Zhang, Marcus Ho-Hin Shum, Jia-Fu Jiang, Hua-Chen Zhu, YiGang Tong*, Yong-Xia Shi, Xue-Bing Ni, Yun-Shi Liao, Wen-Juan Li, Bao-Gui Jiang, Wei Wei, Ting-Ting Yuan, Kui Zheng, Xiao-Ming Cui, Jie Li, Guang-Qian Pei, Xin Qiang, William Yiu-Man Cheung, Lian-Feng Li, Fang- Fang Sun, Si Qin, Ji-Cheng Huang, Gabriel M. Leung, Edward C. Holmes, Yan-Ling Hu, Yi Guan & Wu-Chun Cao. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature 2020;583:282–285. (Co-first author)

4    4. Jing Chen, Xinglou Yang, Haorui Si, Qianchun Gong, Tengcheng Que, Jing Li, Yang Li, Chunguang Wu, Wei Zhang, Ying Chen, Yun Luo, Yan Zhu, Bei Li, Dongsheng Luo, Ben Hu, Haofeng Lin, Rendi Jiang, Tingting Jiang, Qian Li, Meiqin Liu, Shizhe Xie, Jia Su, Xiaoshuang Zheng, Ang Li, Yulin Yao, Yong Yang, Panyu Chen, Aiqiong Wu, Meihong He, Xinhua Lin, Yigang Tong, Yanling Hu, Zheng-Li Shi, Peng Zhou. A bat MERS-like coronavirus circulates in pangolins and utilizes human DPP4 and host proteases for cell entry. Cell 2023;186(4):850-863.e16. (Co-corresponding author)


Admission requirements: